AdvisorShares Psychedelics ETF Logo

AdvisorShares Psychedelics ETF

PSIL

ETF Price

8,03

0,01 Bil. AUM

1,0% Expense Ratio

1,44 NAV

AdvisorShares Psychedelics ETF Profile

About AdvisorShares Psychedelics ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Company
AdvisorShares
Holdings
26
CUSIP

AdvisorShares Psychedelics ETF Sectors

AdvisorShares Psychedelics ETF Sectors
Industry Percentage
Healthcare 100,00%
Basic Materials 0,00%
Technology 0,00%
Real Estate 0,00%
Industrials 0,00%
Financial Servic 0,00%
Energy 0,00%
Consumer Defensi 0,00%
Consumer Cyclica 0,00%
Communication Se 0,00%
Utilities 0,00%